IGBA Names New Chair As More Leaders Join CEO Committee

AAM’s Gaugh Becomes New 2023 Chair Of International Industry Association

14 Apr 2023

The IGBA has named the AAM’s David Gaugh as its chair for the remained of 2023, following the recent departure of Jonathan Kimball. At the same time, the international generics and biosimilars association has added two recently-appointed off-patent industry CEOs to its advisory committee, representing Apotex And Viatris.

Wooden Blocks Management CEO Appointment — David Gaugh is the new IGBA chair for 2023 • Source: Shutterstock

Following the recent departure of Jonathan Kimball as the chair of the International Generic and Biosimilar Medicines Association, the IGBA has announced that David Gaugh, currently interim CEO of the US Association for Accessible Medicines, will take on the position for the remainder of 2023.

Kimball had been named as IGBA chair early this year (Also see "Jonathan Kimball Named IGBA Chair For 2023" - Generics Bulletin, 17 January, 2023